Clinical Trial Update: Minocycline and/or Omega-3 Fatty Acids Added to Treatment as Usual for At Risk Mental States [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating minocycline and/or omega-3 fatty acids added to treatment as usual for individuals at risk of psychosis or with ARMS; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• At Risk Mental State
• Psychosis

Drugs mentioned

• Minocycline (minocycline)
• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Pakistan Institute of Living and Learning | Conditions: At Risk Mental State (ARMS), Psychosis | Phase 2 | Status: COMPLETED